Dominari Holdings Inc. (NASDAQ:DOMH) Short Interest Down 10.2% in September

Dominari Holdings Inc. (NASDAQ:DOMH) was the recipient of a large drop in short interest in the month of September. As of September 30th, there was short interest totalling 4,400 shares, a drop of 10.2% from the September 15th total of 4,900 shares. Approximately 0.1% of the shares of the stock are short sold. Based on an average daily trading volume, of 10,300 shares, the short-interest ratio is currently 0.4 days.

Dominari Trading Down 3.1 %

Shares of DOMH traded down $0.06 during midday trading on Thursday, hitting $1.88. The stock had a trading volume of 14,990 shares, compared to its average volume of 10,572. The business has a 50-day simple moving average of $1.77 and a two-hundred day simple moving average of $2.04. Dominari has a fifty-two week low of $1.50 and a fifty-two week high of $3.20. The firm has a market cap of $11.16 million, a P/E ratio of -0.41 and a beta of 0.94.

Dominari (NASDAQ:DOMH) last announced its quarterly earnings results on Thursday, August 8th. The company reported ($0.51) EPS for the quarter. Dominari had a negative return on equity of 31.02% and a negative net margin of 231.55%. The business had revenue of $6.17 million for the quarter.

Dominari Company Profile

Dominari Holdings Inc, a biotechnology company, focuses on developing small-molecule anticancer therapeutics. The company's pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small molecule treatment for acute myeloid leukemia and acute lymphoblastic leukemia.